Trademark search for:

PRIMVIXLA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2018-03-22 — Application filed
2018-06-07 — Sn assigned for sect 66a subseq desig from ib
2018-06-11 — Application filed
2018-06-12 — Application filed
2018-06-16 — Application filed
2018-06-19 — Assigned to examiner
2018-06-19 — Approved for pub - principal register
2018-07-04 — Notice of publication
2018-07-24 — Published for opposition
2018-10-09 — Registered-principal register
2018-11-08 — Grant of protection created, to be sent to ib
2018-11-18 — Final disposition recorded
2018-11-18 — Final disposition recorded
2018-12-07 — Notification processed by ib
2018-12-20 — Correction transaction received from ib
2024-08-07 — Final status recorded
2025-04-25 — Cancelled section 71
2025-08-18 — Correction from the ib examined, no action is needed
2025-08-28 — Death of international registration

Owner Information

NOVARTIS AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2018-03-22

Status Date:
2024-08-07

Category:
Pharmaceuticals

Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.